The main research direction of SIK1 regulating the TGF-β signaling pathway is further in non-N-cadherin diseases 12, 13, but there is a lack of research in cancer, and even the specific mechanism has not been determined and still needs to be researched in depth. This evidence concerns the gene SIK1 and cancer.